서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 11 of 11

Issue Date	Title / Author(s) / Citation	File	Altmetrics
1998-01	Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) Kim, Hun-Taek; Kim, D.-K.; Cho, Yong-Baik; Kim, Taek-Soo; Jung, I; Kim, Key H.; Heo, Dae Seog; Bang, Yung-Jue; Shin, Sang-Goo; Kim, Noe Kyeong Cancer Chemotherapy and Pharmacology, Vol.41 No.2, pp.109-116	DOI
2006-12	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095	DOI
2009-07	Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma Kim, Won; Yoon, Jung-Hwan; Kim, Jung-Ryul; Jang, In-Jin; Bang, Yung-Jue; Kim, Yoon-Jun; Lee, Hyo-Suk Cancer Chemotherapy and Pharmacology, Vol.64 No.3, pp.497-507	DOI
2011-06	Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors Zamboni, William C.; Maruca, Lauren J.; Strychor, Sandra; Zamboni, Beth A.; Ramalingam, Suresh; Edwards, Robert P.; Kim, J. K.; Bang, Y. J.; Lee, H. Y.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Ramanathan, Ramesh K. Journal of Liposome Research, Vol.21 No.2, pp.158-165	DOI
2012-02	Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies Wu, Huali; Ramanathan, Ramesh K.; Zamboni, Beth A.; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Maruca, Lauren J.; Bang, Yung-Jue; Zamboni, William C. Journal of Clinical Pharmacology, Vol.52 No.2, pp.180-194	DOI
2012-07	Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients Wu, Huali; Ramanathan, Ramesh K.; Zamboni, Beth A.; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Maruca, Lauren J.; Bang, Yung-Jue; Zamboni, William C. International journal of nanomedicine, Vol.7, pp.5555-5564	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2015-08	Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function Devriese, Lot A.; Witteveen, Petronella (Els) O.; Mergui-Roelvink, Marja; Smith, Deborah A.; Lewis, Lionel D.; Mendelson, David S.; Bang, Yung-Jue; Chung, Hyun Choel; Dar, Mohammed M.; Huitema, Alwin D. R.; Beijnen, Jos H.; Voest, Emile E.; Schellens, Jan H. M. British Journal of Clinical Pharmacology, Vol.80 No.2, pp.253-266	DOI
2016-11	Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice Pyo, Kyoung-Ho; Lee, You-Won; Lim, Sun Min; Shin, Eun-Hee Oncotarget, Vol.7 No.45, pp.74107-74119	view file DOI
2018-08	Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Se Hyun; Kim, Yu Jung; Kim, Tae Min; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Esmo Open, Vol.3 No.5, p. e000332	DOI
2020-02	PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation Min, Ahrum; Im, Seock-Ah Cancers, Vol.12 No.2, p. 394	DOI

1